Stock Screener App
Frei
-
Play Store
App Store
Installieren
Installieren
Light
Dark
DE
anmelden
Beobachtungsliste
Top-Listen
Märkte
Neu
Charts
Kryptos
Branchen
Elite
Marktsimulator
Produkte
PHAT
$5.69
3.23%
-0.19
Phathom Pharmaceuticals Inc (PHAT)
Indikator
5
EX
1min
5min
Hourly
Daily
Weekly
Monthly
Line
Candle
Vollbild-Chart
Überblick
Preisverlauf
Optionskette
Finanzen
Forum
Prognose
Finanzdaten der Phathom Pharmaceuticals Inc-Aktie (PHAT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums
2026-09-30
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Periodenlänge
3 Monate
3 Monate
3 Monate
3 Monate
3 Monate
Revenues
14.07%
84.72
74.27
58.30
57.58
49.50
Cost Of Revenue
21.67%
18.37
15.10
12.00
7.65
6.19
Gross Profit
12.13%
66.36
59.18
46.31
49.94
43.31
Operating Expenses
5.22%
66.44
63.14
61.78
55.86
58.59
Selling, General, and Administrative
4.27%
57.70
55.33
54.01
48.37
51.56
Research and Development
11.93%
8.75
7.81
7.77
7.49
7.03
Operating Income/Loss
97.86%
-0.09
-3.97
-15.48
-5.93
-15.27
Nonoperating Income/Loss
1.43%
-13.81
-13.62
-14.89
-15.22
-14.70
Net Income/Loss
20.96%
-13.90
-17.58
-30.37
-21.15
-29.97
Attributable To Parent
20.96%
-13.90
-17.58
-30.37
-21.15
-29.97
Basic Average Shares
1.37%
84.89
83.75
82.05
0.30
73.40
Diluted Average Shares
1.37%
84.89
83.75
82.05
0.30
73.40
Basic Earnings Per Share
23.81%
-0.16
-0.21
-0.37
-0.27
-0.41
Diluted Earnings Per Share
23.81%
-0.16
-0.21
-0.37
-0.27
-0.41
Ähnlich wie PHAT
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
In EDGAR öffnen
|
In Reuters öffnen